Table 1.
Description of Patients With Clostridioides difficile Infection (n = 737)
| Variable | Total a |
|---|---|
| Demographics | |
| Age, median y (IQR) | 72.3 (61.2–83.3) |
| Sex, male, no. (%) | 336 (45.6) |
| Hospital-acquired infection, no. (%) | 357 (48.4) |
| Medical, no. (%) | 496 (67.3) |
| Surgical, no. (%) | 156 (21.2) |
| Nephrology, no. (%) | 83 (11.3) |
| Non-severe infection, no. (%) | 326 (44.2) |
| Clinical data | |
| Temperature, mean °C (SD) | 37.1 (0.8) |
| Albumin, mean g/L (SD) | 23.1 (6.2) |
| Creatinine, median mg/dL (IQR) | 1.1 (0.7–2.1) |
| White blood cell count, median ×109/L (IQR) | 12.3 (8.7–18.1) |
| Initial treatment | |
| Metronidazole, no. (%) | 539 (73.1) |
| Vancomycin, no. (%) | 130 (17.6) |
| Metronidazole and vancomycin, no. (%) | 62 (8.4) |
| Time to treatment, median d (IQR) | 2 (1–5) |
| Outcomes | |
| Recurrence, no. (%) | 107 (14.5) |
| New incident infection, no. (%) | 54 (7.3) |
| 30-day mortality, no. (%) | 94 (12.8) |
| Time to recurrence, median d (IQR) | 27 (22–36) |
| Isolation days, median d (IQR) | 17 (7–34) |
Note. IQR, interquartile range.
a
Sums may not add up to total due to missing data. Percentages exclude missing data.